RxDoctor Payments Data

Alexandra Pelaez, MD

Family Medicine · Marysville, OHNPI 1104238930

Payments from drug & device makers

$325in general payments, 2019–2025

Across 21 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$82
  • AbbVie$55
  • Abbott$43
  • Astellas Pharma US Inc$31
  • AstraZeneca$27
  • Novartis$19
  • plus $68 from 5 others

What the payments were for

  • Food & beverage$325100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$325 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$48,910
Medicare patients
152
Services billed
753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$91,134
EliquisApixaban47$49,264
XareltoRivaroxaban60$41,207
FarxigaDapagliflozin Propanediol23$26,233
JardianceEmpagliflozin14$20,000
RybelsusSemaglutide15$19,735
MounjaroTirzepatide19$18,904
MyrbetriqMirabegron26$15,813
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$12,108
JanuviaSitagliptin Phosphate11$9,577
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$8,449
TrintellixVortioxetine Hydrobromide13$7,209
GemtesaVibegron12$5,741
Ezetimibe62$4,063
CrestorRosuvastatin Calcium13$3,496

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$82$110,86971 claims
PfizerEliquis, Abrysvo$12$52,73458 claims
AstraZenecaFarxiga, Crestor, Symbicort$27$32,56948 claims
Boehringer IngelheimJardiance$12$20,00014 claims
Astellas Pharma US IncMyrbetriq$31$15,81326 claims
AbbVieSynthroid$55$2,17335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →